Understanding the Roles of Hypoxia-Inducible Factor 1 Alpha in Early Host Responses Against Pneumococcal Pneumonia

dc.contributor.advisorGillrie, Mark R.
dc.contributor.authorKang, Hellen
dc.contributor.committeememberKelly, Margaret M.
dc.contributor.committeememberSurewaard, B.
dc.date2023-11
dc.date.accessioned2023-09-15T17:23:06Z
dc.date.available2023-09-15T17:23:06Z
dc.date.issued2023-09-11
dc.description.abstractPneumococcal pneumonia, caused by the bacteria Streptococcus pneumoniae (SP), is the leading infectious cause of death in young children worldwide. Current 2D human and small animal models used to study SP infections do not account for complex organ microenvironments or species-specific immune pathways, respectively. To address this, we created a human vascularized lung on a chip (LoC) containing a ventilated epithelial lined air-liquid interface surrounded by human lung fibroblasts and a functional microvascular network. Single cell RNA sequencing of LoC treated with SP for 6 hours demonstrated early hypoxia inducible factor 1- alpha (HIF-1α) target gene activation. Therefore, we hypothesized that HIF-1α-dependent immune responses play an important role in pneumococcal pneumonia. LoC showed increased CD15+ neutrophil recruitment from perfused whole blood in microvessels to tissue and airway during SP infection, partially mediated by HIF-1α. CXCL family chemokines and IL-17C gene expression, and protein release of the latter, increased 6 hours post-infection in LoC; however, we did not observe vascular or airway dysfunction and microvascular damage until 24 hours post-infection. SP-induced HIF-1α activation may be driven by rapidly activated upstream signaling pathways and may require metabolically active bacteria. Altogether, we have characterized a number of functional roles of HIF-1α during early stages of SP infection and showed the utility of LoC as a pre-clinical human model that can identify key inflammatory and cell-cell interactions during pneumococcal pneumonia.
dc.identifier.citationKang, H. (2023). Understanding the roles of hypoxia-inducible factor 1 alpha in early host responses against pneumococcal pneumonia (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.
dc.identifier.urihttps://hdl.handle.net/1880/117042
dc.identifier.urihttps://doi.org/10.11575/PRISM/41885
dc.language.isoen
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgary
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectPneumonia
dc.subjectHIF-1a
dc.subjectNeutrophil recruitment
dc.subjectLung-on-a-chip
dc.subject.classificationMicrobiology
dc.subject.classificationImmunology
dc.titleUnderstanding the Roles of Hypoxia-Inducible Factor 1 Alpha in Early Host Responses Against Pneumococcal Pneumonia
dc.typemaster thesis
thesis.degree.disciplineMedicine – Microbiology & Infectious Diseases
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameMaster of Science (MSc)
ucalgary.thesis.accesssetbystudentI do not require a thesis withhold – my thesis will have open access and can be viewed and downloaded publicly as soon as possible.
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2023_kang_hellen.pdf
Size:
37.4 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description: